Muhammad Tahir Hayat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Tahir Hayat has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Javaria Qazi
Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan
2 shared publications - Uzma Hameed
Dr. Ikram-Ul-Haq Institute of Industrial Biotechnology, Government College University Lahore, Pakistan
2 shared publications Zubia Shahid
Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University
2 shared publicationsChawalit Ngamcharussrivichai
Center of Excellence in Catalysis for Bioenergy and Renewable Chemicals (CBRC), Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand; Center of Excellence on Petrochemical and Materials Technology (PETROMAT), Chulalongkorn University, Bangkok 10330, Thailand
1 shared publication- Hamid Mukhtar
Institute of Industrial Biotechnology Government College University Lahore Pakistan
1 shared publication - Hamid Mukhtar
Institute of Industrial Biotechnology, Government College University, Lahore 54000, Pakistan
1 shared publication
Latest Publications
- 29 June 2026
- Published by Taylor & Francis in Spectroscopy Letters
Classification of autism related molecular signatures by simple machine learning models applied to ATR-FTIR spectra of pediatric sera
Background Autism spectrum disorder (ASD) begins early and continues for life with strong personal and societal implications. Complexity of the condition and absence of auxiliary methods that can complement clinical evaluation make an early identification challenging. ASD is reported to be associated with metabolic changes and hence biochemical alterations in the affected children. This study is one of the initial investigations to employ Attenuated Total Reflectance–Fourier Transform Infrared (ATR-FTIR) spectroscopy coupled with machine learning to identify the biochemical alterations in the blood sera of children with ASD as compared to controls. Methods ATR-FTIR spectra from lyophilized blood sera of 13 children with ASD, in the age range of 1.8 to 8 years along with 9 age-matched neurotypical controls were obtained and baseline corrected using rubber-band method. After baseline correction and vector normalization, spectral features for both groups were analyzed using principal component analysis (PCA) for dimensionality reduction, followed by supervised classification with linear discriminant analysis (LDA). Results Results of LDA applied to three selected PCs, including PC3 (4.38% variance, p = 0.0021), PC5 (2.18%, p = 0.095), and PC6 (1.31%, p = 0.083) under leave-one-out cross-validation achieved 86.36% accuracy, 92.31% sensitivity, 77.78% specificity, 88.89% F1-score, and AUC-ROC of 0.803. Analysis of the pre-processed mean spectra identified eight prominent spectral variations including two in the protein and lipid C-H stretching region (3293 and 2962 cm−1) and six in the bio-fingerprint region (1630, 1533, 1456, 1394, 1237, and 1086 cm−1). Conclusions We conclude that ATR-FTIR spectroscopy coupled with machine learning can detect biochemical variations in the sera of children with and without ASD by applying LDA to PCA-reduced pre-processed spectra.
- 29 June 2026
- Published by Taylor & Francis in Spectroscopy Letters
Classification of autism related molecular signatures by simple machine learning models applied to ATR-FTIR spectra of pediatric sera
Background Autism spectrum disorder (ASD) begins early and continues for life with strong personal and societal implications. Complexity of the condition and absence of auxiliary methods that can complement clinical evaluation make an early identification challenging. ASD is reported to be associated with metabolic changes and hence biochemical alterations in the affected children. This study is one of the initial investigations to employ Attenuated Total Reflectance–Fourier Transform Infrared (ATR-FTIR) spectroscopy coupled with machine learning to identify the biochemical alterations in the blood sera of children with ASD as compared to controls. Methods ATR-FTIR spectra from lyophilized blood sera of 13 children with ASD, in the age range of 1.8 to 8 years along with 9 age-matched neurotypical controls were obtained and baseline corrected using rubber-band method. After baseline correction and vector normalization, spectral features for both groups were analyzed using principal component analysis (PCA) for dimensionality reduction, followed by supervised classification with linear discriminant analysis (LDA). Results Results of LDA applied to three selected PCs, including PC3 (4.38% variance, p = 0.0021), PC5 (2.18%, p = 0.095), and PC6 (1.31%, p = 0.083) under leave-one-out cross-validation achieved 86.36% accuracy, 92.31% sensitivity, 77.78% specificity, 88.89% F1-score, and AUC-ROC of 0.803. Analysis of the pre-processed mean spectra identified eight prominent spectral variations including two in the protein and lipid C-H stretching region (3293 and 2962 cm−1) and six in the bio-fingerprint region (1630, 1533, 1456, 1394, 1237, and 1086 cm−1). Conclusions We conclude that ATR-FTIR spectroscopy coupled with machine learning can detect biochemical variations in the sera of children with and without ASD by applying LDA to PCA-reduced pre-processed spectra.
- 5 December 2025
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 240, 107356
First report on ATR-FTIR and machine learning-based sputum profiling for TB detection: A compendium of potential biomarkers
- 5 December 2025
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 240, 107356
First report on ATR-FTIR and machine learning-based sputum profiling for TB detection: A compendium of potential biomarkers
- 3 May 2024
- Published by Elsevier in Biologicals
- Vol. 86, 101766
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era
- 3 May 2024
- Published by Elsevier in Biologicals
- Vol. 86, 101766
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era
- 30 April 2024
- Published by MZB Standard Enterprise in Science Reviews. Biology
- Vol. 3 (1) , 1-8
The Role of Non-Coding RNAs in Cancer Progression: A Concise Comprehensive Review
Cancer is among one of the most widespread diseases globally and poses a great threat to human wellbeing. Non-coding RNAs (ncRNAs) compose most transcripts but cannot undergo translation. Thus, no proteins are made by them. However, studies have shown that ncRNAs can mimic both oncogenes and tumour suppressor genes involved in cancer. This review discusses recent research on the involvement of ncRNAs in the progression, diagnosis, and treatment of cancer. These ncRNAs consist of microRNAs, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs). This concise paper aims to inform researchers, clinicians, and scientists in navigating the dynamic field of ncRNAs in cancer with the goal of fostering collaboration to translate discoveries into practical clinical advancements
- 30 April 2024
- Published by MZB Standard Enterprise in Science Reviews. Biology
- Vol. 3 (1) , 1-8
The Role of Non-Coding RNAs in Cancer Progression: A Concise Comprehensive Review
Cancer is among one of the most widespread diseases globally and poses a great threat to human wellbeing. Non-coding RNAs (ncRNAs) compose most transcripts but cannot undergo translation. Thus, no proteins are made by them. However, studies have shown that ncRNAs can mimic both oncogenes and tumour suppressor genes involved in cancer. This review discusses recent research on the involvement of ncRNAs in the progression, diagnosis, and treatment of cancer. These ncRNAs consist of microRNAs, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs). This concise paper aims to inform researchers, clinicians, and scientists in navigating the dynamic field of ncRNAs in cancer with the goal of fostering collaboration to translate discoveries into practical clinical advancements
- Open Access
- 19 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1075
CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Antibiotic resistance is rising to dangerously high levels throughout the world. To cope with this problem, scientists are working on CRISPR-based research so that antibiotic-resistant bacteria can be killed and attacked almost as quickly as antibiotic-sensitive bacteria. Nuclease activity is found in Cas9, which can be programmed with a specific target sequence. This mechanism will only attack pathogens in the microbiota while preserving commensal bacteria. This article portrays the delivery methods used in the CRISPR-Cas system, which are both viral and non-viral, along with its implications and challenges, such as microbial dysbiosis, off-target effects, and failure to counteract intracellular infections. CRISPR-based systems have a lot of applications, such as correcting mutations, developing diagnostics for infectious diseases, improving crops productions, improving breeding techniques, etc. In the future, CRISPR-based systems will revolutionize the world by curing diseases, improving agriculture, and repairing genetic disorders. Though all the drawbacks of the technology, CRISPR carries great potential; thus, the modification and consideration of some aspects could result in a mind-blowing technique to attain all the applications listed and present a game-changing potential.
- 19 June 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (6) , 1075
Open AccessCRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Antibiotic resistance is rising to dangerously high levels throughout the world. To cope with this problem, scientists are working on CRISPR-based research so that antibiotic-resistant bacteria can be killed and attacked almost as quickly as antibiotic-sensitive bacteria. Nuclease activity is found in Cas9, which can be programmed with a specific target sequence. This mechanism will only attack pathogens in the microbiota while preserving commensal bacteria. This article portrays the delivery methods used in the CRISPR-Cas system, which are both viral and non-viral, along with its implications and challenges, such as microbial dysbiosis, off-target effects, and failure to counteract intracellular infections. CRISPR-based systems have a lot of applications, such as correcting mutations, developing diagnostics for infectious diseases, improving crops productions, improving breeding techniques, etc. In the future, CRISPR-based systems will revolutionize the world by curing diseases, improving agriculture, and repairing genetic disorders. Though all the drawbacks of the technology, CRISPR carries great potential; thus, the modification and consideration of some aspects could result in a mind-blowing technique to attain all the applications listed and present a game-changing potential.
- 22 May 2022
- Published by Elsevier in Journal of Biotechnology
- Vol. 352, 47-58
Sustainable processing of algal biomass for a comprehensive biorefinery
- 22 May 2022
- Published by Elsevier in Journal of Biotechnology
- Vol. 352, 47-58
Sustainable processing of algal biomass for a comprehensive biorefinery